Cannabinoid control of brain bioenergetics: Exploring the subcellular localization of the CB1 receptor

Molecular Metabolism

Volumn 3, Issue 4, 2014, Pages 495-504

  Hebert Chatelain, Etienne ^a,b   Reguero, Leire ^c   Puente, Nagore ^c   Lutz, Beat ^d   Chaouloff, Francis ^a,b   Rossignol, Rodrigue ^b,e   Piazza, Pier Vincenzo ^a,b   Benard, Giovanni ^a,b   Grandes, Pedro ^c   Marsicano, Giovanni ^a,b  

^a INSTITUT FRANÇOIS MAGENDIE   (France)

^b UNIVERSITÉ DE BORDEAUX   (France)

^c UNIVERSITY OF THE BASQUE COUNTRY UPV EHU   (Spain)

^d UNIVERSITY MEDICAL CENTER MAINZ   (Germany)

^e Laboratoire Maladies Rares Génétique et Métabolisme Bordeaux University   (France)

Author keywords

Antibodies; Brain bioenergetics; Electron microscopy; Mitochondria; Organelle purification

Indexed keywords

2,3 DIHYDRO 5 METHYL 3 (MORPHOLINOMETHYL) 6 (1 NAPHTHOYL)PYRROLO[1,2,3 DE][1,4]BENZOXAZINE; CANNABINOID 1 RECEPTOR AGONIST; CANNABINOID 1 RECEPTOR ANTIBODY; MITOCHONDRIAL CANNABINOID 1 RECEPTOR ANTIBODY; RECEPTOR ANTIBODY; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL TISSUE; ARTICLE; BIOENERGY; BRAIN; BRAIN BIOENERGY; BRAIN FUNCTION; BRAIN MITOCHONDRION; CELL FRACTIONATION; CELLULAR DISTRIBUTION; CONTROLLED STUDY; ELECTRON MICROSCOPY; ENRICHMENT CULTURE; IMMUNOPRECIPITATION; INTERMETHOD COMPARISON; MITOCHONDRIAL RESPIRATION; MOUSE; NONHUMAN; OXYGEN CONSUMPTION; PRIORITY JOURNAL; PURIFICATION; WESTERN BLOTTING;

EID: 84902315628     PISSN: 22128778     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.molmet.2014.03.007     Document Type: Article

References (32)

1. Bournat J.C., Brown C.W. Mitochondrial dysfunction in obesity. Current Opinion in Endocrinology Diabetes and Obesity 2010, 17:446-452.
2. Hojlund K., Mogensen M., Sahlin K., Beck-Nielsen H. Mitochondrial dysfunction in type 2 diabetes and obesity. Endocrinology and Metabolism Clinics of North America 2008, 37:713-731. x.
3. Schneeberger M., Dietrich M.O., Sebastian D., Imbernon M., Castano C., Garcia A., et al. Mitofusin 2 in POMC neurons connects ER stress with leptin resistance and energy imbalance. Cell 2013, 155:172-187.
4. Dietrich M.O., Liu Z.W., Horvath T.L. Mitochondrial dynamics controlled by mitofusins regulate Agrp neuronal activity and diet-induced obesity. Cell 2013, 155:188-199.
5. Sivitz W.I., Yorek M.A. Mitochondrial dysfunction in diabetes: from molecular mechanisms to functional significance and therapeutic opportunities. Antioxidants & Redox Signaling 2010, 12:537-577.
6. Diano S., Horvath T.L. Mitochondrial uncoupling protein 2 (UCP2) in glucose and lipid metabolism. Trends in Molecular Medicine 2012, 18:52-58.
7. Abizaid A., Horvath T.L. Brain circuits regulating energy homeostasis. Regulatory Peptides 2008, 149:3-10.
8. Sims N.R., Anderson M.F. Isolation of mitochondria from rat brain using Percoll density gradient centrifugation. Nature Protocols 2008, 3:1228-1239.
9. Benard G., Massa F., Puente N., Lourenco J., Bellocchio L., Soria-Gomez E., et al. Mitochondrial CB(1) receptors regulate neuronal energy metabolism. Nature Neuroscience 2012, 15:558-564.
10. Morozov Y.M., Dominguez M.H., Varela L., Shanabrough M., Koch M., Horvath T.L., et al. Antibodies to cannabinoid type 1 receptor co-react with stomatin-like protein 2 in mouse brain mitochondria. The European Journal of Neuroscience 2013, 38:2341-2348.
11. Piomelli D. The molecular logic of endocannabinoid signalling. Nature Reviews Neuroscience 2003, 4:873-884.
12. Silvestri C., Di Marzo V. The endocannabinoid system in energy homeostasis and the etiopathology of metabolic disorders. Cell Metabolism 2013, 17:475-490.
13. Nam D.H., Lee M.H., Kim J.E., Song H.K., Kang Y.S., Lee J.E., et al. Blockade of cannabinoid receptor 1 improves insulin resistance, lipid metabolism, and diabetic nephropathy in db/db mice. Endocrinology 2012, 153:1387-1396.
14. Vickers S.P., Webster L.J., Wyatt A., Dourish C.T., Kennett G.A. Preferential effects of the cannabinoid CB1 receptor antagonist, SR 141716, on food intake and body weight gain of obese (fa/fa) compared to lean Zucker rats. Psychopharmacology 2003, 167:103-111.
15. Pagotto U., Marsicano G., Cota D., Lutz B., Pasquali R. The emerging role of the endocannabinoid system in endocrine regulation and energy balance. Endocrine Reviews 2006, 27:73-100.
16. Bartova A., Birmingham M.K. Effect of delta9-tetrahydrocannabinol on mitochondrial NADH-oxidase activity. The Journal of Biological Chemistry 1976, 251:5002-5006.
17. Matsuda L.A., Lolait S.J., Brownstein M.J., Young A.C., Bonner T.I. Structure of a cannabinoid receptor and functional expression of the cloned cDNA. Nature 1990, 346:561-564.
18. Munro S., Thomas K.L., Abu-Shaar M. Molecular characterization of a peripheral receptor for cannabinoids. Nature 1993, 365:61-65.
19. Athanasiou A., Clarke A.B., Turner A.E., Kumaran N.M., Vakilpour S., Smith P.A., et al. Cannabinoid receptor agonists are mitochondrial inhibitors: a unified hypothesis of how cannabinoids modulate mitochondrial function and induce cell death. Biochemical and Biophysical Research Communications 2007, 364:131-137.
20. Howlett A.C., Barth F., Bonner T.I., Cabral G., Casellas P., Devane W.A., et al. International Union of Pharmacology. XXVII. Classification of cannabinoid receptors. Pharmacological Reviews 2002, 54:161-202.
21. Marsicano G., Wotjak C.T., Azad S.C., Bisogno T., Rammes G., Cascio M.G., et al. The endogenous cannabinoid system controls extinction of aversive memories. Nature 2002, 418:530-534.
22. Benard G., Faustin B., Passerieux E., Galinier A., Rocher C., Bellance N., et al. Physiological diversity of mitochondrial oxidative phosphorylation. American Journal of Physiology. Cell Physiology 2006, 291:C1172-C1182.
23. Clark J.B., Nicklas W.J. The metabolism of rat brain mitochondria. Preparation and characterization. The Journal of Biological Chemistry 1970, 245:4724-4731.
24. Howlett A.C., Song C., Berglund B.A., Wilken G.H., Pigg J.J. Characterization of CB1 cannabinoid receptors using receptor peptide fragments and site-directed antibodies. Molecular Pharmacology 1998, 53:504-510.
25. McIntosh H.H., Song C., Howlett A.C. CB1 cannabinoid receptor: cellular regulation and distribution in N18TG2 neuroblastoma cells. Brain Research Molecular Brain Research 1998, 53:163-173.
26. Fukudome Y., Ohno-Shosaku T., Matsui M., Omori Y., Fukaya M., Tsubokawa H., et al. Two distinct classes of muscarinic action on hippocampal inhibitory synapses: M2-mediated direct suppression and M1/M3-mediated indirect suppression through endocannabinoid signalling. The European Journal of Neuroscience 2004, 19:2682-2692.
27. Song C., Howlett A.C. Rat brain cannabinoid receptors are N-linked glycosylated proteins. Life Sciences 1995, 56:1983-1989.
28. Kristian T. Isolation of mitochondria from the CNS. Current Protocols in Neuroscience 2010, 22. Chapter 7, Unit 7.
29. Horvath T.L., Diano S., Tschop M. Brain circuits regulating energy homeostasis. Neuroscientist 2004, 10:235-246.
30. Maunsbach A.B., Afzelius B.A. Biomedical electron microscopy. Illustrated methods and interpretations 1999, Academic Press, San Diego.
31. Hollinshead M., Sanderson J., Vaux D.J. Anti-biotin antibodies offer superior organelle-specific labeling of mitochondria over avidin or streptavidin. The Journal of Histochemistry and Cytochemistry 1997, 45:1053-1057.
32. Chance B., Williams G.R. Amethod for the localization of sites for oxidative phosphorylation. Nature 1955, 176:250-254.